Hemab Therapeutics Holdings, Inc.

COAG chart

Hemab Therapeutics Holdings, Inc. news

• Hemab Therapeutics Holdings, Inc. (COAG) - What Are Investment Firms Thinking About This Stock?

  MarketBeat · Oct 26, 6:38 AM EDT

• Hemab Therapeutics Holdings, Inc. Estimates – NASDAQ:COAG

  TradingView · Oct 24, 8:44 AM EDT

• Hemab Therapeutics (COAG) Stock Price, News & Analysis

  MarketBeat · Oct 24, 3:00 AM EDT

• Hemab Therapeutics Holdings, Inc.'s (NASDAQ:COAG) Lock-Up Period Will Expire on October 28th

  MarketBeat · Oct 21, 1:51 AM EDT

• Hemab Therapeutics Holdings (COAG) Joins Russell Indices, Is The Stock Still Trading At A Discount?

  Yahoo Finance · Sep 28, 9:07 PM EDT

• Hemab Therapeutics Strengthens Board of Directors with Appointment of Keli Walbert

  Yahoo Finance · Sep 24, 4:01 PM EDT

• Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding

  Yahoo Finance · Sep 17, 8:00 AM EDT

• Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

  Yahoo Finance · Aug 11, 7:00 AM EDT

• Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

  Yahoo Finance · Jul 14, 7:45 AM EDT

• Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress

  Yahoo Finance · Jul 12, 6:28 AM EDT

• Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress

  Yahoo Finance · Jun 26, 9:00 AM EDT

• Hemab Therapeutics Details Post-IPO Pipeline Push, Sutacimig Phase III Plans

  marketbeat.com · Jun 8, 11:03 PM EDT

Hemab Therapeutics Holdings, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-09-24
• 10-Q10-Q2026-08-11
• 8-K8-K2026-08-11
• 10-Q10-Q2026-05-21
• 8-K8-K2026-05-21
• 8-K8-K2026-05-11
• 8-K8-K2026-05-04
• S-1S-12026-04-10

About Hemab Therapeutics Holdings, Inc.

Ticker

COAG (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Cambridge, MA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2114044

Frequently asked questions